Skip to main content

Headline Roundup August 31st, 2022

FDA Authorizes Updated COVID-19 Booster Shots for Expected Fall Omicron Wave

Summary from the AllSides News Team

The FDA updated its emergency use authorizations for the Pfizer-BioNTech and Moderna COVID-19 vaccines to include updated booster shots designed to fight the highly contagious BA.4 and BA.5 Omicron subvariants

The updated booster shots came ahead of an expected fall or winter wave of COVID-19 cases. The U.S. currently has a seven-day average of about 90,000 daily new cases, but last winter’s Omicron wave saw as much as 806,000 average daily cases. 

Updated boosters are expected to be available shortly after Labor Day; they still need the CDC’s approval before being administered at pharmacies nationwide. Single doses of the updated Pfizer booster are authorized for individuals 12 and up, but the updated Moderna booster is only authorized for adults. The CDC currently recommends a second dose of the pre-update Pfizer and Moderna boosters for adults aged 50 and up. 

Coverage was widespread and mostly balanced across the spectrum, although right-rated outlets were less likely to feature coverage prominently on homepages. NPR (Lean Left bias) stood out by calling the updated boosters “double-barreled,” like a double-barreled shotgun.

Featured Coverage of this Story

From the Right
FDA authorizes updated COVID-19 booster shots targeting omicron variant
FDA authorizes updated COVID-19 booster shots targeting omicron variant

AP Photo/Steven Senne

News

The U.S. Food and Drug Administration (FDA) announced Wednesday that it has authorized updated coronavirus booster shots targeting the highly-contagious omicron variant.

"Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months following primary or booster vaccination," it said in a statement.

Open on Fox News Digital
From the Center
FDA authorizes Pfizer and Moderna Covid boosters targeted against Omicron strains
FDA authorizes Pfizer and Moderna Covid boosters targeted against Omicron strains

JOEL SAGET/AFP VIA GETTY IMAGES

News

The Food and Drug Administration on Wednesday authorized new Covid booster shots from Moderna and Pfizer that more closely match the strains of the coronavirus that are currently circulating in the U.S.

Pfizer’s booster, made with partner BioNTech, is being authorized for people as young as 12 years old. The Moderna booster is being authorized for people ages 18 and up.

Use of the new boosters still requires the signoff the Centers for Disease Control and Prevention. The CDC’s vaccine advisory panel is scheduled to meet Thursday and Friday and could vote...

Open on STAT
From the Left
Omicron-specific vaccine boosters get FDA sign-off
Omicron-specific vaccine boosters get FDA sign-off

Illustration by Alex Castro / The Verge

News

COVID-19 vaccines designed to target the omicron variant have just been authorized by the Food and Drug Administration. Both Pfizer / BioNTech and Moderna got the FDA’s sign-off for their booster doses of the reformulated shot. This is the first update to COVID-19 vaccines to be authorized in the United States.

The Pfizer / BioNTech booster is available to people 12 and older, and the Moderna shot will be available to people 18 and older. They’ll only be boosters — they can’t be used by people who haven’t already had their...

Open on The Verge
Possible Paywall

More headline roundups

More News about Coronavirus on AllSides

News from the Left

News from the Center

News from the Right